Back to Search
Start Over
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
- Publication Year :
- 2013
-
Abstract
- All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of treatment with arsenic trioxide with or without ATRA have shown high efficacy and reduced hematologic toxicity.
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1105015909
- Document Type :
- Electronic Resource